Advanced Search
XIONG Lun, GUAN Dongliang, LI Jian, HUANG Wei. Synthetic process of telavancin[J]. Journal of China Pharmaceutical University, 2017, 48(2): 172-177. DOI: 10.11665/j.issn.1000-5048.20170207
Citation: XIONG Lun, GUAN Dongliang, LI Jian, HUANG Wei. Synthetic process of telavancin[J]. Journal of China Pharmaceutical University, 2017, 48(2): 172-177. DOI: 10.11665/j.issn.1000-5048.20170207
shu

Synthetic process of telavancin

More Information
    Graphical Abstract
    • Abstract
  • New process reported the synthesis of telavancin using decyl alcohol as the starting material. After methanesulfonylation, nucleophilic substitution with ethanolamine, Fmoc protection, and Parikh-Doering oxidation, the intermdiate N-(9-fluorenyl-9-methoxycarbonyl)decylaminoethyl acetaldehyde( 5 )was obtained. Vancomycin hydrochloride and intermediate 5 were then subject to reductive amination reaction, Fmoc deprotection, and Mannich reaction to give the telavancin product. The process have been deeply studied on the two key reactions of reductive amination and Mannich reaction, and the reaction conditions have been optimized. The overall yield is 46% based on starting material vancomycin.
    • FullText(HTML)
    • References (12)
  • [1]
    Chang MH,Kish TD,Fung HB.Telavancin:a lipoglycopeptide antimicrobial for the treatment of complicated skin and skin structure infections caused by Gram-positive bacteria in adults[J].Clin Ther,2010,32(13):2160-2185.
    [2]
    Karlowsky JA,Nichol K,Zhanel GG.Telavancin:mechanisms of action,in vitro activity,and mechanisms of resistance[J].Clin Infect Dis,2015,61(Suppl 2):S58-S68.
    [3]
    Hegde SS, Janc JW. Efficacy of telavancin, a lipoglycopeptide antibiotic,in experimental models of Gram-positive infection[J].Expert Rev Anti-Infe,2014,12(12):1463-1475.
    [4]
    Higgins DL,Chang R,Debabov DV,et al.Telavancin,a multifunctional lipoglycopeptide,disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus[J].Antimicrob Agents Chemother,2005,49(3):1127-1134.
    [5]
    Lee J, Liu J. Process for preparing glycopeptide phosphonate derivatives:US,7074890[P].2004-08-25[2016-04-04] .
    [6]
    Leadbetter MR.Glycopeptide phosphonate derivatives:US,8541375[P].2011-12-16[2016-04-04] .
    [7]
    Liang YH, Feng WH. Process improvement on the synthesis of lipoglycopeptide antibiotic telavancin[J].Chin J Synt Chem(合成化学),2011,19(4):550-553.
    [8]
    Ma S,Jia CY,Yuan H,et al.Synthesis of telavancin[J].Chin J New Drugs(中国新药杂志),2013,23(23):2809-2812.
    [9]
    Benito-Garagorri D. Process for the synthesis of telavancin, its pharmaceutically acceptable salts as well as an N-protected imine-derivative of telavancin:WO,2013034676[P].2011-09-09[2016-04-04] .
    [10]
    Li XP,Wu JP,Liang XM,et al.Application of DMSO as oxidant in organic syntheses[J].Chin J Org Chem(有机化学),2001,21(8):549-556.
    [11]
    Tidwell TT.Oxidation of alcohols by activated dimethyl sulfoxide and related reactions:an update[J].Synthesis,1990(10):857-870.DOI: 10.1002/chin.199112358.
    [12]
    Parikh JR,Doering WE.Sulfur trioxide in the oxidation of alcohols by dimethyl sulfoxide[J].J Am Chem Soc,1967,89(21):5505-5507.
    • Related Articles

  • Related Articles

    [1]WANG Dong, ZHONG Jian, WANG Ling, ZHOU Zhihui, JIANG Haiting, LUO Peng, WANG Xizhi, WANG Chongyi. Improved synthetic process of apremilast[J]. Journal of China Pharmaceutical University, 2021, 52(5): 536-540. DOI: 10.11665/j.issn.1000-5048.20210504
    [2]ZHANG Chunlai, LUO Hongjun, JIANG Qi, LI Guoxian, GU Guoqing, ZHANG Jie. Improved process of dexrabeprazole sodium[J]. Journal of China Pharmaceutical University, 2018, 49(3): 291-294. DOI: 10.11665/j.issn.1000-5048.20180306
    [3]MA Li, ZHANG Menghan, XU Zhiwei, SUN Ying′ai, ZHU Jing, HUANG Yingbo, ZHANG Dayong. A new synthetic process of dapagliflozin[J]. Journal of China Pharmaceutical University, 2017, 48(1): 42-45. DOI: 10.11665/j.issn.1000-5048.20170106
    [4]LIU Bao, WU Kai, SUN Ruiqin, JIANG Yuwei, ZHANG Xiaoqing. Practical synthesis of tofisopam[J]. Journal of China Pharmaceutical University, 2014, 45(6): 671-673. DOI: 10.11665/j.issn.1000-5048.20140609
    [5]SHI Yubai, WANG Yanfang, MA Shaohua. A new synthetic process of bicyclic pyrrolidine intermediate in telaprevir[J]. Journal of China Pharmaceutical University, 2014, 45(5): 529-534. DOI: 10.11665/j.issn.1000-5048.20140504
    [6]CHENG Haibo, XU Bin, ZHANG Huibin, ZHOU Jinpei. Synthetic process of antitumor drug dacomitinib[J]. Journal of China Pharmaceutical University, 2014, 45(2): 165-169. DOI: 10.11665/j.issn.1000-5048.20140206
    [7]WU Yong, SUN Xiao-wei, WU Xiao-ming, SUN Hong-bin. Synthesis of aliskiren[J]. Journal of China Pharmaceutical University, 2011, 42(5): 400-406.
    [8]Practical synthesis of lapatinib[J]. Journal of China Pharmaceutical University, 2010, 41(4): 317-320.
    [9]Improved Synthetic Process of Nabumetone[J]. Journal of China Pharmaceutical University, 2004, (1): 92-93.
    [10]Improve on the Synthetic Process of Bezafibrate[J]. Journal of China Pharmaceutical University, 2003, (3): 80-81.

Catalog

    Get Citation
    PDF
    XML
    Article views (943) PDF downloads (1808) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：433231

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return